Conditions: SARS-CoV-2 Infection
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 128
Healthy volunteers: yes

Brief summary:
The objective of this study is to evaluate the safety and immunogenicity of MT-2766 in Japanese adults.

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None

Interventions: intervention 1: MT-2766 High dose (3.75 µg) intervention 2: Placebo intervention 3: MT-2766 Low dose
Intervention descriptions: intervention 1: Subjects will receive two doses of MT-2766 high dose (3.75 µg) given 21 days apart into the deltoid region of the alternating arm (each arm will be injected once) intervention 2: Subjects will receive two doses of placebo given 21 days apart into the deltoid region of the alternating arm (each arm will be injected once) intervention 3: Subjects will receive two doses of MT-2766 low dose given 21 days apart into the deltoid region of the alternating arm (each arm will be injected once)

Protocol document:
SAP_002.pdf: 























































































































Prot_000.pdf: